TOL2649G
Drug
TOLMAR, INC.
Total Payments
$67,179
Transactions
9
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $67,179 | 9 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $67,179 | 9 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TOL2649G | TOLMAR, INC. | $67,179 | 0 |
Top Doctors Receiving Payments for TOL2649G
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Bethesda, MD | $67,179 | 9 |
Ad
Manufacturing Companies
- TOLMAR, INC. $67,179
Product Information
- Type Drug
- Total Payments $67,179
- Total Doctors 0
- Transactions 9
About TOL2649G
TOL2649G is a drug associated with $67,179 in payments to 0 healthcare providers, recorded across 9 transactions in the CMS Open Payments database. The primary manufacturer is TOLMAR, INC..
Payment data is available from 2018 to 2018. In 2018, $67,179 was paid across 9 transactions to 0 doctors.
The most common payment nature for TOL2649G is "Unspecified" ($67,179, 100.0% of total).
TOL2649G is associated with 1 research study, including "TOL2649G" ($67,179).